Excitement has built recently about new avenues for psychiatric treatment: psychedelic drugs such as Ketamine and psilocybin; trans‐cranial magnetic stimulation (TMS). We see the revival of older practices such as electro‐convulsive shock therapy (ECT) and therapeutic lesioning, and medicines borrowed from other fields, like GLP‐1s.
The typical conundrum with cannabis use by adolescents and first episode psychosis — which came first? — was displaced by Steven Batki, M.D., in a plenary session at the Cape Cod Symposium on Addictive Disorders (CCSAD) in September. Bakti, who is a professor of psychiatry at the University of California San Francisco Weill Institute for Neurosciences, presented his conclusions allowing the...
In the last 10 years, mindfulness has become a popular approach for managing strong or distressing feelings for adults and children. Particularly for children, mindfulness‐based interventions (MBIs) have been touted as a modality for the treatment of conditions ranging from attention‐deficit hyperactivity disorder (ADHD) to anxiety, autism spectrum disorders, depression, and stress. Jon...
Lasting effects of adolescent cannabis use are even more pronounced than those for alcohol, researchers suggest in a new study of the role of impaired cognition on substance use.